TABLE 1.
Vector | Measured ADA enzyme activity, avg proviral copy no./cell, calculated ADA enzyme activity/integrated provirus for:
|
||||||
---|---|---|---|---|---|---|---|
B-LCL cells
|
TJF-2 cells
|
||||||
Expt 1 | Expt 2 | Avg ADA/provirusc | Expt 1 | Expt 2 | Expt 3 | Avg ADA/provirus | |
Noneb | 1 | 2 | 5 | 2 | 1 | ||
PA317/LASN | 8, 0.5, 16 | 16, 1.0, 16 | 16 | 14, 0.4, 32 | 30, 1.0, 30 | 28, 1.0, 28 | 30 |
PG13/LASN | 51, 3.0, 17 | 24, 1.2, 20 | 19 | 155, 2.0, 76 | 99, 2.0, 50 | 43, 2.0, 43 | 49 |
PG13/ADA(MPSV) | 81, 0.8, 101 | 79, 0.8, 98 | 100d | 189, 2.4, 79 | 118, 2.3, 52 | 136, 2.3, 60 | 64e |
PG13/ADA(SL3-3) | 38, 0.9, 43 | 32, 0.9, 36 | 40 | 137, 1.4, 98 | 53, 1.3, 41 | 66, 1.1, 60 | 67e |
ADA enzyme activity is expressed as nanomoles of inosine produced per minute per 108 cells.
Values in this row are measured ADA enzyme activities.
Avg ADA/provirus, average value for calculated ADA enzyme activity per integrated provirus.
P < 0.05 compared with values for PA317/LASN, PG13/LASN, and PG13/ADA(SL3-3).
P < 0.05 compared with values for PA317/LASN and PG13/LASN.